Stock Fundamentals

Company Information

Company Name
Bicara Therapeutics Inc. Common Stock
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US0554771032
Currency: USD
Full Time Employees: 103
Phone: 617 468 4219
Fiscal Year End: December
IPO Date: Sep 13, 2024
Description:

Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines a clinically validated epidermal growth factor receptor directed monoclonal antibody bound to human transforming growth factor beta for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts.

Address:

116 Huntington Avenue, Boston, MA, United States, 02116

Directors & Officers

Name Title Year Born
Dr. Claire Mazumdar Clemon M.B.A., Ph.D. CEO & Director 1990
Mr. Ryan Cohlhepp Pharm.D. President, COO & Director 1977
Mr. Ivan Hyep M.B.A. CFO & Treasurer 1985
Ms. Rachel Frank Vice President of Investor Relations and Corporate Communications NA
Ms. Lara S. Meisner J.D. Chief Legal Officer, Compliance Officer & Corporate Secretary 1972
Ms. Pauline Dufresne Chief People Officer NA
Ms. Rachel Salazar SVP of R&D Strategy and Operations NA
Ms. Sathish Hasige Ph.D. Senior VP and Head of Technical Operations & Supply Chain NA
Ms. Angela Windt VP & Head of Regulatory Affairs NA
Dr. Jeltje Schulten M.B.A., M.D. Senior Vice President of Clinical & Medical Affairs NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Apr 21, 2026 Ivan Hyep N/A Sale 9.20K $23.00 $211.60K
Apr 20, 2026 Claire Mazumdar N/A Sale 15.00K $23.61 $354.15K
Apr 15, 2026 Ryan Cohlhepp N/A Sale 12.50K $23.01 $287.63K
Mar 23, 2026 Ivan Hyep N/A Sale 9.20K $18.52 $170.38K
Mar 20, 2026 Claire Mazumdar N/A Sale 1.60K $18.95 $30.24K
Mar 19, 2026 Claire Mazumdar N/A Sale 6.91K $18.78 $129.68K
Mar 18, 2026 Claire Mazumdar N/A Sale 6.50K $18.84 $122.44K
Mar 16, 2026 Ryan Cohlhepp N/A Sale 12.50K $19.66 $245.75K
Mar 09, 2026 Claire Mazumdar N/A Sale 36.77K $19.17 $704.80K
Mar 06, 2026 Claire Mazumdar N/A Sale 3.82K $18.75 $71.57K
Mar 05, 2026 Claire Mazumdar N/A Sale 1.79K $18.74 $33.47K
Mar 04, 2026 Claire Mazumdar N/A Sale 2.63K $18.73 $49.28K
Mar 04, 2026 David Raben N/A Sale 16.30K $18.52 $301.88K
Mar 04, 2026 Ivan Hyep N/A Sale 2.96K $18.25 $54.07K
Mar 03, 2026 David Raben N/A Sale 200.00 $18.45 $3.69K
Mar 03, 2026 Ivan Hyep N/A Sale 13.56K $18.22 $246.97K
Mar 03, 2026 Ryan Cohlhepp N/A Sale 17.39K $18.16 $315.84K
Jan 22, 2026 Ryan Cohlhepp N/A Sale 3.83K $18.10 $69.29K
Jan 22, 2026 Ivan Hyep N/A Sale 1.88K $18.15 $34.16K
Jan 15, 2026 Ryan Cohlhepp N/A Sale 149.00 $18.02 $2.68K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
RA Capital Management, LLC 7.26M Mar 31, 2026 11.06% $1.53 4.31%
T. Rowe Price Investment Management,Inc. 6.61M Mar 31, 2026 10.07% $0.09 94.18%
Siren, L.L.C. 5.80M Mar 31, 2026 8.85% $3.20 11.23%
Vestal Point Capital LP 5.43M Mar 31, 2026 8.27% $3.02 51.75%
Deep Track Capital, LP 4.06M Mar 31, 2026 6.19% $1.32 55.41%
HHG PLC 3.34M Mar 31, 2026 5.09% $0.03 26.19%
Red Tree Management, LLC 3.17M Mar 31, 2026 4.83% $56.39 0.00%
TPG GP A, LLC 3.01M Mar 31, 2026 4.59% $1.63 0.00%
BlackRock Inc 2.84M Mar 31, 2026 4.33% $0.00 12.47%
Omega Fund Management LLC 2.39M Mar 31, 2026 3.65% $29.16 8.50%
Royalty Pharma Sub-Manager, LLC 2.39M Mar 31, 2026 3.64% $27.02 89.06%
Vanguard Group Inc 2.19M Dec 31, 2025 3.33% $0.00 -0.67%
FMR Inc 2.10M Mar 31, 2026 3.20% $0.00 -37.23%
Citadel Advisors Llc 1.66M Mar 31, 2026 2.53% $0.01 114.87%
Franklin Resources Inc 1.62M Mar 31, 2026 2.47% $0.01 0.10%
State Street Corp 1.42M Mar 31, 2026 2.16% $0.00 -13.95%
T. Rowe Price Associates, Inc. 1.38M Mar 31, 2026 2.10% $0.00 -11.76%
Atle Fund Management AB 1.17M Mar 31, 2026 1.78% $0.75 950.29%
Geode Capital Management, LLC 830.91K Mar 31, 2026 1.27% $0.00 2.40%
Fidelity International Ltd 679.90K Mar 31, 2026 1.04% $0.01 -10.36%

Shares Statistics

Shares Outstanding: 65.70M
Shares Float: 36.63M
% Insiders: 1,022.40%
% Institutions: 10,419.00%
Short % Float: 20.94%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 T. Rowe Price US Small-Cap Core Equity 2.18M 3.33% ▲ 54.23% Mar 31, 2026
2 T. Rowe Price Small-Cap Stock 2.18M 3.33% ▲ 4.84% Mar 31, 2026
3 Vanguard Total Stock Mkt Idx Inv 1.37M 2.09% ▲ 0.00% Apr 30, 2026
4 T. Rowe Price Instl Small-Cap Stock 1.20M 1.82% ▲ 5.08% Mar 31, 2026
5 T. Rowe Price U.S. SC Core Eq Tr-D 1.03M 1.58% ▲ 60.49% Mar 31, 2026
6 Fidelity Select Biotechnology 944.90K 1.44% ▲ 0.00% Mar 31, 2026
7 State Street® SPDR® S&P® Biotech ETF 779.69K 1.19% ▼ 0.72% Apr 30, 2026
8 iShares Russell 2000 ETF 749.71K 1.14% ▲ 0.85% Apr 30, 2026
9 T. Rowe Price Small-Cap Value 705.03K 1.07% ▲ 0.00% Mar 31, 2026
10 Franklin Biotechnology Discv A(acc)USD 665.23K 1.01% ▲ 0.00% Apr 30, 2026

Valuation Metrics

Enterprise Value: $813.22M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $1.31B
EBITDA: $-173.93M
Book Value: $7.84
Earnings/Share: $-2.77
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -21.09%
ROE (TTM): -32.34%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 14.58x 0.00x 0.07x N/A -0.01x
2024-12-31 27.93x 0.00x 0.14x N/A -0.01x
2023-12-31 15.32x 0.00x 0.07x N/A -0.01x
2022-12-31 0.21x 0.00x 3.58x -336.21x 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about BCAX.US!